| |
| |
|
| Insider
Information: |
Pops Richard F |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,303,786 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$37,782,416 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,303,786 |
|
|
| Total
Value |
$37,782,416 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Director |
2024-05-17 |
31,611 |
2005-11-23 |
0 |
Premium* |
|
|
Alkermes Plc |
ALKS |
Director and CEO, Alke... |
2024-02-08 |
1,179,675 |
2011-09-16 |
0 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
Director |
2013-05-30 |
60,000 |
|
0 |
Premium* |
|
|
Acceleron Pharma Inc |
XLRN |
Director |
2019-01-25 |
32,500 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2024-05-17 |
4 |
AS |
$141.84 |
$297,860 |
D/D |
(2,100) |
31,611 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2024-03-13 |
4 |
AS |
$140.33 |
$3,255,621 |
D/D |
(23,200) |
29,512 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2024-03-08 |
4 |
AS |
$140.05 |
$238,078 |
D/D |
(1,700) |
29,512 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2024-03-11 |
4 |
AS |
$140.00 |
$14,000 |
D/D |
(100) |
29,512 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2024-02-20 |
4 |
AS |
$132.47 |
$1,987,047 |
D/D |
(15,000) |
29,512 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2023-01-03 |
4 |
AS |
$119.20 |
$1,788,045 |
D/D |
(15,000) |
29,512 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-10-29 |
4 |
AS |
$107.13 |
$589,237 |
D/D |
(5,500) |
37,759 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-11-12 |
4 |
AS |
$103.30 |
$425,893 |
D/D |
(4,123) |
33,636 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-11-26 |
4 |
AS |
$91.37 |
$376,790 |
D/D |
(4,124) |
29,512 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-05-01 |
4 |
D |
$84.39 |
$105,741 |
D/D |
(1,253) |
43,259 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2022-05-09 |
4 |
AS |
$76.29 |
$1,144,463 |
D/D |
(15,000) |
29,512 |
0 |
% |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2015-03-03 |
4 |
D |
$72.80 |
$445,754 |
D/D |
(6,123) |
526,940 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2015-12-01 |
4 |
AS |
$71.99 |
$3,614,344 |
D/D |
(50,000) |
553,497 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2015-12-07 |
4 |
AS |
$71.87 |
$2,702,433 |
D/D |
(37,500) |
553,497 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2015-09-17 |
4 |
AS |
$70.88 |
$3,563,261 |
D/D |
(50,000) |
542,917 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2018-02-17 |
4 |
D |
$67.26 |
$173,598 |
D/D |
(2,581) |
643,855 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2015-09-10 |
4 |
AS |
$67.20 |
$3,378,387 |
D/D |
(50,000) |
542,917 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2015-05-20 |
4 |
D |
$62.10 |
$237,657 |
D/D |
(3,827) |
531,346 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2015-05-21 |
4 |
D |
$61.80 |
$236,509 |
D/D |
(3,827) |
535,644 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2005-11-23 |
4 |
S |
$61.55 |
$1,242,011 |
D/D |
(20,000) |
0 |
|
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2017-03-03 |
4 |
D |
$60.97 |
$372,953 |
D/D |
(6,117) |
630,406 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2018-03-03 |
4 |
D |
$60.05 |
$347,029 |
D/D |
(5,779) |
666,352 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2015-05-28 |
4 |
D |
$59.92 |
$388,102 |
D/D |
(6,477) |
542,917 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2015-10-05 |
4 |
D |
$59.77 |
$563,033 |
D/D |
(9,420) |
553,497 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2017-03-01 |
4 |
D |
$59.71 |
$491,652 |
D/D |
(8,234) |
623,523 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
